Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 4/20 | 0.47 |
| ▸ | CA2 | P00918 | 4/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.35 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.35 |
| ▸ | MGLL | Q99685 | 2/20 | 0.35 |
| ▸ | FAAH | O00519 | 1/20 | 0.35 |
| ▸ | DPP7 | Q9UHL4 | 5/20 | 0.35 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.33 |
| ▸ | CA7 | P43166 | 1/20 | 0.33 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.33 |
| ▸ | DPP8 | Q6V1X1 | 4/20 | 0.33 |
| ▸ | DPP4 | P27487 | 3/20 | 0.33 |
| ▸ | DPP9 | Q86TI2 | 3/20 | 0.33 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL15021865 | 0.98 | CA1 (0.46) | CA1CA2L3MBTL1PTGS1PTGS2 | |
| SCHEMBL20377214 | 0.94 | CA1 (0.41) | CA1CA2PTGS1PTGS2MGLL | |
| Trifluoroacetic Acid SCHEMBL30150804 | 0.91 | CA1 (0.40) | CA1CA2L3MBTL1 | |
| SCHEMBL30153762 | 0.90 | CA1 (0.39) | CA1CA2MGLLSIGMAR1 | |
| SCHEMBL10182253 | 0.84 | PTGS1 (0.35) | CA1CA2PTGS1PTGS2MGLL | |
| SCHEMBL2219783 | 0.82 | CA2 (0.43) | CA1CA2L3MBTL1PTGS1PTGS2 | |
| SCHEMBL43970 | 0.80 | PTPN1 (0.42) | CA2PTGS1PTGS2MGLLFAAH | |
| SCHEMBL12094816 | 0.80 | MGLL (0.39) | CA1CA2PTGS1PTGS2MGLL | |
| SCHEMBL5165799 | 0.79 | CA2 (0.46) | CA1CA2L3MBTL1PTGS1PTGS2 | |
| SCHEMBL12409955 | 0.79 | POLB (0.36) | DPP7SLC15A1POLBDPP8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 220 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024091979-A1 | CD276 (B7-H3) ANTIBODY-DRUG CONJUGATES | BRICKBIO, INC. (US) | 2024-05-02 | — | — | WO | claimed |
| EP-4171644-A2 | SAPONIN DERIVATIVES FOR USE IN MEDICINE | Sapreme Technologies B.V. (NL) | 2023-05-03 | — | — | EP | claimed |
| EP-4171639-A2 | SAPONIN DERIVATIVES FOR USE IN MEDICINE | Sapreme Technologies B.V. (NL) | 2023-05-03 | — | — | EP | claimed |
| EP-4171643-A1 | THERAPEUTIC COMBINATION OF GALNAC-OLIGONUCLEOTIDE CONJUGATE AND SAPONIN, AND USES THEREOF | Sapreme Technologies B.V. (NL) | 2023-05-03 | — | — | EP | claimed |
| CN-115568232-A | Tin-based perovskite solar cell with tin-based perovskite thin film subjected to surface treatment by multifunctional ionic salt and preparation method of tin-based perovskite solar cell | 山东大学 | 2023-01-03 | — | — | CN | claimed |
| EP-4003425-A2 | BIOACTIVE SAPONIN LINKED TO A FUNCTIONAL MOIETY | SAPREME TECHNOLOGIES B.V. (NL) | 2022-06-01 | — | — | EP | claimed |
| EP-4003427-A1 | SAPONIN DERIVATIVES WITH IMPROVED THERAPEUTIC WINDOW | SAPREME TECHNOLOGIES B.V. (NL) | 2022-06-01 | — | — | EP | claimed |
| WO-2021261998-A1 | THERAPEUTIC COMBINATION OF GALNAC-OLIGONUCLEOTIDE CONJUGATE AND SAPONIN, AND USES THEREOF | SAPREME TECHNOLOGIES B.V. (NL) | 2021-12-30 | — | — | WO | claimed |
| WO-2021260054-A2 | SAPONIN DERIVATIVES WITH IMPROVED THERAPEUTIC WINDOW | SAPREME TECHNOLOGIES B.V. (NL) | 2021-12-30 | — | — | WO | claimed |
| WO-2021260061-A2 | SAPONIN DERIVATIVES WITH IMPROVED THERAPEUTIC WINDOW | SAPREME TECHNOLOGIES B.V. (NL) | 2021-12-30 | — | — | WO | claimed |
| US-8420802-B2 | Polymer support | UNIVERSITY OF CAPE TOWN (ZA) | 2013-04-16 | — | — | US | claimed |
| EP-2478049-A1 | A POLYMER SUPPORT | University of Cape Town (ZA) | 2012-07-25 | — | — | EP | claimed |
| US-20120178916-A1 | Polymer Support | UNIVERSITY OF CAPE TOWN (ZA) | 2012-07-12 | — | — | US | claimed |
| WO-2011083360-A1 | A POLYMER SUPPORT | UNIVERSITY OF CAPE TOWN (ZA) | 2011-07-14 | — | — | WO | claimed |
| US-20110142762-A1 | Conjugates for medical imaging comprising carrier, targeting moiety and a contrast agent | NOVOZYMES BIOPHARMA DK A/S (DK) | 2011-06-16 | — | — | US | claimed |
| EP-1605979-B1 | CONJUGATES FOR MEDICAL IMAGING COMPRISING CARRIER, TARGETING MOIETY AND A CONTRAST AGENT | UPPERTON LTD (GB) | 2008-10-22 | — | — | EP | claimed |
| JP-2006518727-A | — | — | 2006-08-17 | — | — | JP | claimed |
| US-20060171892-A1 | Conjugates for medical imaging comprising carrier, targetting moiety and a contrast agent | NOVOZYMES BIOPHARMA UK LIMITED (GB) | 2006-08-03 | — | — | US | claimed |
| EP-1605979-A1 | CONJUGATES FOR MEDICAL IMAGING COMPRISING CARRIER, TARGETING MOIETY AND A CONTRAST AGENT | Upperton Limited (GB) | 2005-12-21 | — | — | EP | claimed |
| WO-2004071536-A1 | CONJUGATES FOR MEDICAL IMAGING COMPRISING CARRIER, TARGETING MOIETY AND A CONTRAST AGENT | UPPERTON LIMITED (GB) | 2004-08-26 | — | — | WO | claimed |